Supportive Care

Camp Bluebird: A  Survivorship Program  for Life
Camp Bluebird—is it a special place or a special program or is it just that special feeling you have after you’ve been there? Can you explain Camp Bluebird to others, or do you just have to experience it firsthand? Is it like the camps that we remember as children, rustic and full of splinters, or is it butterflies and fireflies? It is all of these things and more. Read More ›

Cancer anorexia-cachexia syndrome (CACS) is underrecognized and underreported in patients with advanced lung cancer receiving routine clinical care... Read More ›

Dyspnea is the most prevalent symptom in patients with cancer, occurring in 22% to 55% of all affected individuals, and up to 79% at the end of life. Read More ›

Patients with cancer face many challenges, including eating well to maintain a good nutritional status and avoid weight loss and malnutrition. Read More ›

A novel fixed-dose combination of netupitant and palonosetron, referred to as NEPA, was found to be highly effective in preventing chemotherapy-induced nausea and vomiting in 2 studies presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting. Read More ›

Evidence suggests that cancer patients commonly experience spiritual pain or distress but believe that their spiritual needs are not being adequately addressed by healthcare providers. Read More ›

I spent five years of my life being treated for cancer, but since then I’ve spent fifteen years being treated for nothing other than looking different than anyone else. Read More ›

Extremely high levels of methotrexate can lead to precipitation of the drug in the renal tubules, delayed drug clearance, and the potential for acute renal failure. Read More ›

Hand-foot skin reaction (HFSR), also known as hand-foot syndrome or palmar-plantar erythrodysesthesia (PPE), is an adverse effect of several chemotherapeutic agents. Read More ›

OnPART can predict 6 common side effects of dose-dense doxorubicin plus cyclophosphamide plus paclitaxel chemotherapy in patients with breast cancer with a high degree of accuracy, according to the results of a study presented at the CTRC-AACR San Antonio Breast Cancer Symposium. Read More ›

Page 6 of 13


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: